DMed
DMed become an international brand for providing drug innovation services and solutions.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD618—927m (Dealroom.co estimates Dec 2020.)
Shanghai Shanghai (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$8.0m | Series A | ||
$6.0m | Series B | ||
$50.0m | Series B | ||
$100m | Series C | ||
N/A | Merger | ||
| Total Funding | AUD253m | ||
